Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

921 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry.
Villaschi A, Chiarito M, Pagnesi M, Stolfo D, Baldetti L, Lombardi CM, Adamo M, Loiacono F, Sammartino AM, Colombo G, Tomasoni D, Inciardi RM, Maccallini M, Gasparini G, Montella M, Contessi S, Cocianni D, Perotto M, Barone G, Merlo M, Vitale C, Rosano GMC, Cappelletti AM, Sinagra G, Metra M, Pini D. Villaschi A, et al. Among authors: sinagra g. Eur J Heart Fail. 2024 May 14. doi: 10.1002/ejhf.3234. Online ahead of print. Eur J Heart Fail. 2024. PMID: 38741569
Reply to the letter regarding the article 'Subclinical systolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients: A systematic review and meta-analysis'.
Faggiano A, Gherbesi E, Gnan E, Paldino A, Merlo M, Sinagra G, Carugo S. Faggiano A, et al. Among authors: sinagra g. Eur J Heart Fail. 2024 May 13. doi: 10.1002/ejhf.3297. Online ahead of print. Eur J Heart Fail. 2024. PMID: 38741025 No abstract available.
Intra-hospital variation of gut microbiota product, trimethylamine N-oxide (TMAO) predicts future major adverse cardiovascular events after myocardial infarction.
Aleksova A, Fluca AL, Stornaiuolo M, Barbati G, Pierri A, Zwas DR, Santon D, D'Errico S, Marketou M, Sinagra G, Avraham Y, Novellino E, Janjusevic M. Aleksova A, et al. Among authors: sinagra g. Hellenic J Cardiol. 2024 May 8:S1109-9666(24)00111-8. doi: 10.1016/j.hjc.2024.05.007. Online ahead of print. Hellenic J Cardiol. 2024. PMID: 38729348 Free article.
Hepatic T1-time, cardiac structure and function and cardiovascular outcomes in patients with dilated cardiomyopathy.
Inciardi RM, Merlo M, Bellicini M, Setti M, De Luca A, Di Meo N, Rondi P, Pagnesi M, Adamo M, Lombardi CM, Rizzi JG, Farina D, Mantovani A, Targher G, Sinagra G, Metra M; NAFLD-DCM group. Inciardi RM, et al. Among authors: sinagra g. Eur J Intern Med. 2024 May 7:S0953-6205(24)00167-5. doi: 10.1016/j.ejim.2024.04.009. Online ahead of print. Eur J Intern Med. 2024. PMID: 38719725
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies.
Castrichini M, De Luca A, De Angelis G, Neves R, Paldino A, Dal Ferro M, Barbati G, Medo K, Barison A, Grigoratos C, Gigli M, Stolfo D, Brun F, Groves DW, Quaife R, Eldemire R, Graw S, Addison J, Todiere G, Gueli IA, Botto N, Emdin M, Aquaro GD, Garmany R, Pereira NL, Taylor MRG, Ackerman MJ, Sinagra G, Mestroni L, Giudicessi JR, Merlo M. Castrichini M, et al. Among authors: sinagra g. J Am Coll Cardiol. 2024 May 14;83(19):1841-1851. doi: 10.1016/j.jacc.2024.02.041. J Am Coll Cardiol. 2024. PMID: 38719365
The additive prognostic value of end-systolic pressure-volume relation by stress CMR in patients with known or suspected coronary artery disease.
Meloni A, De Luca A, Nugara C, Cavallaro C, Cappelletto C, Barison A, Todiere G, Grigoratos C, Novo G, Grigioni F, Emdin M, Sinagra G, Mavrogeni S, Quaia E, Cademartiri F, Pepe A. Meloni A, et al. Among authors: sinagra g. Int J Cardiovasc Imaging. 2024 Apr 27. doi: 10.1007/s10554-024-03104-z. Online ahead of print. Int J Cardiovasc Imaging. 2024. PMID: 38676849
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries.
Wallner M, Biber ME, Stolfo D, Sinagra G, Benson L, Dahlström U, Gudbjörnsdottir S, Cosentino F, Mol PGM, Rosano GMC, Butler J, Metra M, Lund LH, Ferrannini G, Savarese G. Wallner M, et al. Among authors: sinagra g. Eur Heart J Cardiovasc Pharmacother. 2024 Apr 17:pvae026. doi: 10.1093/ehjcvp/pvae026. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38632048
Management of hypertrophic cardiomyopathy.
Zhang Y, Adamo M, Zou C, Porcari A, Tomasoni D, Rossi M, Merlo M, Liu H, Wang J, Zhou P, Metra M, Sinagra G, Zhang J. Zhang Y, et al. Among authors: sinagra g. J Cardiovasc Med (Hagerstown). 2024 Apr 17. doi: 10.2459/JCM.0000000000001616. Online ahead of print. J Cardiovasc Med (Hagerstown). 2024. PMID: 38625835
921 results